 |
|
|
| |
Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute hepatitis C virus genotype 1 monoinfection: The HepNet Acute HCV IV Study
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-7 Barcelona
Katja Deterding, Christoph Spinner, Eckart Schott, Tania Welzel, Guido
Gerken, Hartwig Klinker, Ulrich Spengler, Johannes Wiegand, Julian Schulze
zur Wiesch, Anita Pathil, Markus Cornberg, Andreas Umgelter, Caroline
Zöllner, Stefan Zeuzem, Heiko von der Leyen, Dorothee von Witzendorff,
Michael P. Manns, Heiner Wedemeyer
for the HepNet Acute HCV IV Study Group
|
| |
|
|
|
|
|
